Christopher Andrew Johnson

512 total citations
9 papers, 339 citations indexed

About

Christopher Andrew Johnson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Christopher Andrew Johnson has authored 9 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Christopher Andrew Johnson's work include Immune cells in cancer (4 papers), Immunotherapy and Immune Responses (2 papers) and Cancer-related Molecular Pathways (2 papers). Christopher Andrew Johnson is often cited by papers focused on Immune cells in cancer (4 papers), Immunotherapy and Immune Responses (2 papers) and Cancer-related Molecular Pathways (2 papers). Christopher Andrew Johnson collaborates with scholars based in United States and Taiwan. Christopher Andrew Johnson's co-authors include Ann Richmond, Sheau‐Chiann Chen, Anna E. Vilgelm, Jinming Yang, Gregory D. Ayers, Chi Yan, Mark C. Kelley, Gregory D. Ayers, Douglas B. Johnson and Rami N. Al‐Rohil and has published in prestigious journals such as ACS Nano, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Christopher Andrew Johnson

8 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Andrew Johnson United States 8 200 132 117 80 49 9 339
Claire Hardy United States 8 123 0.6× 188 1.4× 43 0.4× 84 1.1× 54 1.1× 15 351
Roi Villar-Vázquez Spain 6 175 0.9× 263 2.0× 86 0.7× 63 0.8× 62 1.3× 6 466
Lorenzo Spagnuolo Switzerland 10 164 0.8× 101 0.8× 212 1.8× 35 0.4× 55 1.1× 11 374
Maicol Mancini France 10 211 1.1× 337 2.6× 39 0.3× 131 1.6× 38 0.8× 15 499
Eman Barhoush Saudi Arabia 6 381 1.9× 124 0.9× 239 2.0× 57 0.7× 28 0.6× 6 536
Hao Mo China 13 135 0.7× 226 1.7× 54 0.5× 86 1.1× 13 0.3× 32 436
Jingqi Chen China 12 87 0.4× 180 1.4× 67 0.6× 40 0.5× 128 2.6× 17 392
Claire Banissi France 9 287 1.4× 146 1.1× 311 2.7× 49 0.6× 49 1.0× 17 539
Anna Mizutani Japan 14 157 0.8× 392 3.0× 48 0.4× 41 0.5× 14 0.3× 21 549
Jacob Pourat United States 8 173 0.9× 163 1.2× 37 0.3× 35 0.4× 34 0.7× 9 388

Countries citing papers authored by Christopher Andrew Johnson

Since Specialization
Citations

This map shows the geographic impact of Christopher Andrew Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Andrew Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Andrew Johnson more than expected).

Fields of papers citing papers by Christopher Andrew Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Andrew Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Andrew Johnson. The network helps show where Christopher Andrew Johnson may publish in the future.

Co-authorship network of co-authors of Christopher Andrew Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Andrew Johnson. A scholar is included among the top collaborators of Christopher Andrew Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Andrew Johnson. Christopher Andrew Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shattuck-Brandt, Rebecca L., Sheau‐Chiann Chen, Emily Murray, et al.. (2020). Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition. Clinical Cancer Research. 26(14). 3803–3818. 22 indexed citations
2.
Yang, Jinming, Chi Yan, Anna E. Vilgelm, et al.. (2020). Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity. Cancer Immunology Research. 9(2). 200–213. 56 indexed citations
3.
Zanotelli, Matthew R., et al.. (2020). The Physical Microenvironment of Tumors: Characterization and Clinical Impact. Biophysical Reviews and Letters. 15(2). 51–82. 9 indexed citations
4.
Vilgelm, Anna E., Nabil Saleh, Rebecca L. Shattuck-Brandt, et al.. (2019). MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science Translational Medicine. 11(505). 88 indexed citations
5.
Ou, Yu‐Chuan, Xiaona Wen, Christopher Andrew Johnson, et al.. (2019). Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies. ACS Nano. 14(1). 651–663. 54 indexed citations
6.
Lavender, Nicole, Jinming Yang, Sheau‐Chiann Chen, et al.. (2017). The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo. BMC Cancer. 17(1). 88–88. 30 indexed citations
7.
Vilgelm, Anna E., David K. Flaherty, Christopher Andrew Johnson, et al.. (2017). MDM2 Antagonists Counteract Drug-Induced DNA Damage. EBioMedicine. 24. 43–55. 10 indexed citations
8.
Vilgelm, Anna E., Christopher Andrew Johnson, Nripesh Prasad, et al.. (2016). Abstract 5126: The link between therapy-induced senescence and anti-tumor immune microenvironment in melanoma. Cancer Research. 76(14_Supplement). 5126–5126.
9.
Vilgelm, Anna E., Christopher Andrew Johnson, Nripesh Prasad, et al.. (2015). Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment. JNCI Journal of the National Cancer Institute. 108(6). djv406–djv406. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026